Table 3

(A) Overall outcomes on basic characteristics of missions

Length of missionTotal number of patientsGender distributionAge
Studies (n)Total length (days)Average (days)Studies (n)Patients (n, %)Average per study (n)Studies (n)Female (n, %)Male (n, %)Studies (n)Mean (years)Studies (n)Median (years)
Clefts1816892837 642 (78)13441812 210 (45.8)14 435 (54.2)129.2234.5
Post-burn contractures32385358 (1)724143 (44.8)176 (55.2)227.614.0
Noma228144269 (1)673102 (58.6)72 (41.4)123.9117.0
General reconstructive45714410 277 (21)25691143 (44.8)176 (55.2)124.0NANA
Totals272764148 546 (100)2612 598 (45.9)14 859 (54.1)165
Overall mean or median10 (+/-SD 3.8)1184 (+/-SD 2134.4)13.4 (SD+/-8.5)4.5 (Q25-75 2.9-13)
(B) Overall outcomes on patient safety
Follow-up length not reportedFollow-up length<180 daysFollow-up length>180 days
Studies (n)Follow-up rate* (%)Complication rate† (n, %)Studies (n)Follow-up rate* (%)Complication rate† (n, %)Studies (n)Follow-up rate* (%)Complication rate† (n, %)
Clefts7NA111/11 992 (0.9)681.0739/12 513 (5.9)954.3181/887 (20.4)
Post-burn contractures3NA24/383 (6.3)177.49/31 (29.0)1100.028/50 (56.0)
Noma1NA17/34 (50.0)397.6158/240 (65.8)0NANA
General reconstructive1NA6/266 (2.3)11007/30 (23.3)0NANA
Total studies 12 11 10
Overall rate 158/12 675 (1.25) 81.3 913/12 814 (7.1) 56.0 209/937 (22.3)
  • *The follow-up rate: the number of patients who completed follow-up divided by the total number of patientsi ncluded for follow-up. For clarity reasons only percentages are displayed,patients numbers are omitted.

  • †The complication rate: the number of patients with complications divided by the total number of patients who completed follow-up. Displayed are the patient numbers, between brackets the complication percentage.

  • NA, not available.